Posted by ABMN Staff on Mar 29th, 2024
VYNE Therapeutics Inc. (NASDAQ:VYNE – Get Free Report) was the recipient of a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 12,400 shares, a drop of 63.4% from the February...
More of this article »